-
Streptavidin Magnetic Beads for NSCLC Assay Design
2026-09-24
Benzyl-activated Streptavidin Magnetic Beads provide a practical way to capture biotinylated probes and reagents when testing molecular interactions in cancer research. This article maps the SNORA38B–E2F1–GAB2 findings in NSCLC to careful assay design, controls, and workflow limits.
-
Central Circuits Behind Opioid Mechanical Hypersensitivity
2026-09-24
Yin et al. identify a brain-to-spinal opioid pathway linking lateral parabrachial, hypothalamic, and spinal neurons to morphine-induced mechanical hypersensitivity and analgesic tolerance in mice. Their findings point to a central mechanism that can help distinguish mechanical opioid side effects from thermal responses and guide circuit-focused pain research.
-
JC-1 Mitochondrial Membrane Potential Assay Guide
2026-09-23
Connect herbicide-induced oxidative stress to mitochondrial depolarization with a ratiometric JC-1 workflow, while keeping ROS and membrane-potential measurements distinct. Practical controls, preparation guidance, and troubleshooting help researchers adapt the assay to plant material and other mitochondrial samples.
-
Redox-Responsive Peptide Coacervates for mRNA Delivery
2026-09-23
Ren and colleagues developed HBpep-SS4, a single-component peptide coacervate that combines high mRNA encapsulation with glutathione-triggered intracellular release. The system accommodated diverse RNA cargos, entered cells through phagocytosis, and supported substantial genome-editing activity, while also revealing important questions about cargo-specific performance and translation in more complex models.
-
Ivermectin: Research Profile and Workflow Limits
2026-09-22
Ivermectin is an FDA-approved broad-spectrum anti-parasitic used in selected human parasitic diseases and topical conditions. Its validated ion-channel mechanism supports parasitology drug development, while current evidence does not establish ivermectin as a treatment for pancreatic cancer or GSDMC-driven disease.
-
L-Alanyl-L-Glutamine: Practical Research Guide
2026-09-22
L-Alanyl-L-glutamine provides a stable, water-soluble dipeptide format for aqueous nutritional, gastrointestinal-barrier, and catabolic-stress research workflows. It is appropriate for water-based preparation but should not be selected for DMSO- or ethanol-based delivery, and prepared solutions should not be stored long term.
-
Zolmitriptan: Mechanism-Aware Migraine Assays
2026-09-21
Zolmitriptan supports mechanism-aware migraine and cluster headache research by linking 5-HT1B receptor agonism to vascular and neuropeptide endpoints. This guide also shows how a lysosome-focused antiviral study can improve assay design without conflating unrelated mechanisms.
-
AZD6482 as a Cell-State Control for RNA-Foci Studies
2026-09-21
AZD6482 is a selective PI3Kβ inhibitor that can help researchers separate kinase-pathway effects from HSP90-driven RNA-foci regulation in DM1 models. This article connects biochemical selectivity, platelet and metabolic evidence, and cell-state-aware RNA-FISH assay design without treating AZD6482 as an established DM1 therapy.
-
Mecamylamine and the Gut–Brain Cholinergic Axis
2026-09-20
The 2026 Neuron study on Bacteroides fragilis positions gut–vagus–brain cholinergic signaling as a translational mechanism in seizure control. This article explains how Mecamylamine hydrochloride can help researchers interrogate nicotinic receptor contributions to microbiota-linked neural phenotypes while keeping validated findings distinct from exploratory assay extensions.
-
(-)-JQ1: A Rigor Framework for Translational AML
2026-09-19
A thought-leadership guide to using (-)-JQ1 as an inactive stereochemical control when testing BET biology in inv(16) AML, with practical assay design, mechanistic interpretation, and translational strategy.
-
VX-765 and the Translational Logic of Pyroptosis
2026-09-18
Caspase-1 sits at the intersection of inflammatory cytokine maturation and pyroptotic cell death. This thought-leadership analysis uses recent photodynamic therapy research to show how VX-765 and its active metabolite VRT-043198 can help translational researchers separate pathway causality from downstream association across cancer, inflammatory, and infectious disease models.
-
Dual-Action Inhibitors Reveal p38α Dephosphorylation
2026-09-18
The reference study shows that some p38α kinase inhibitors do more than block catalysis: they also expose the activation-loop phospho-threonine to WIP1, accelerating dephosphorylation. Its biochemical and X-ray structural results suggest that stabilizing a phosphatase-compatible kinase conformation may improve the specificity and durability of p38 MAPK inhibition.
-
Zolmitriptan Research Workflows
2026-09-17
Build a mechanistic Zolmitriptan workflow that connects 5-HT1B/1D/1F receptor signaling with vascular and neuronal readouts. The guide also shows how lysosomal assays can strengthen experimental controls without overstating evidence for an antiviral role.
-
CGI1746, σ1R, and Ferroptosis at MAMs
2026-09-17
The reference study identifies CGI1746 as a ferroptosis inhibitor that acts through the sigma-1 receptor (σ1R) at mitochondria-associated membranes (MAMs). Its experiments connect MAM-dependent calcium transfer, mitochondrial reactive oxygen species, and lipid trafficking to ferroptosis execution, offering a mechanistic framework for studying ferroptosis in cancer and cisplatin-associated kidney injury.
-
Isochlorogenic Acid A Disrupts HBV via HO-1/ROS
2026-09-16
The reference study shows that isochlorogenic acid A (ICAA) restricts hepatitis B virus at several stages, including transcription, genome production, cccDNA-associated replication, capsid formation, and envelopment. Its mechanistic contribution is to connect these phenotypes with HO-1 upregulation, intracellular ROS modulation, and possible changes in thiol-dependent viral protein assembly.